Artwork

Contenido proporcionado por Jill Waggoner, MD, Jill Waggoner, and MD. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Jill Waggoner, MD, Jill Waggoner, and MD o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Phases of Vaccine Development

17:48
 
Compartir
 

Manage episode 281231695 series 2804304
Contenido proporcionado por Jill Waggoner, MD, Jill Waggoner, and MD. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Jill Waggoner, MD, Jill Waggoner, and MD o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

In this episode, Dr. Jill Waggoner discusses the various phases of vaccine development. Information to help explain the methods via which vaccines are developed and tested before being released to the public. This brief discussion gives the listener the information they need to understand how vaccines come into being.

Before vaccines are licensed by the FDA, they are tested extensively in the laboratory and with human volunteers to ensure their safety. First, researchers use computers to predict how the vaccine will interact with the human immune system. Then the vaccines are tested on animals including mice, guinea pigs, rabbits, and monkeys. Finally, the vaccines go into human trials.

Vaccine development and approval follows the same general steps that are used to test drugs and other biological agents. A sponsor who wishes to begin clinical trials with a vaccine must submit an Investigational New Drug application (IND) to FDA. The IND describes the vaccine, its method of manufacturing, and quality control tests for release. Also included are information about the vaccine’s safety and ability to elicit a protective immune response (immunogenicity) in animal testing, as well as a proposed plan for testing the drug on humans.

Dr. Jill Waggoner is a residency trained, board certified Family Practice Physician with nearly three decades of experience. She is located in the Dallas Fort Worth Metroplex holds a Medical Degree and a Master's Degree from the University of Oklahoma. She has certifications in both Preventive Medicine and Wellness Coordination from the prestigious Cooper Institute.

Connect with Dr. Jill:

Dr. Jill’s Instagram

Dr. Jill’s Facebook

Dr. Jill’s Twitter

Dr. Jill’s Website

To become a patient visit:

Methodist Premier Wellness or call (972) 298-2099

Connect with Dr. Jill:

Dr. Jill’s Instagram

Dr. Jill’s Facebook

Dr. Jill’s Website

  continue reading

32 episodios

Artwork
iconCompartir
 
Manage episode 281231695 series 2804304
Contenido proporcionado por Jill Waggoner, MD, Jill Waggoner, and MD. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente Jill Waggoner, MD, Jill Waggoner, and MD o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.

In this episode, Dr. Jill Waggoner discusses the various phases of vaccine development. Information to help explain the methods via which vaccines are developed and tested before being released to the public. This brief discussion gives the listener the information they need to understand how vaccines come into being.

Before vaccines are licensed by the FDA, they are tested extensively in the laboratory and with human volunteers to ensure their safety. First, researchers use computers to predict how the vaccine will interact with the human immune system. Then the vaccines are tested on animals including mice, guinea pigs, rabbits, and monkeys. Finally, the vaccines go into human trials.

Vaccine development and approval follows the same general steps that are used to test drugs and other biological agents. A sponsor who wishes to begin clinical trials with a vaccine must submit an Investigational New Drug application (IND) to FDA. The IND describes the vaccine, its method of manufacturing, and quality control tests for release. Also included are information about the vaccine’s safety and ability to elicit a protective immune response (immunogenicity) in animal testing, as well as a proposed plan for testing the drug on humans.

Dr. Jill Waggoner is a residency trained, board certified Family Practice Physician with nearly three decades of experience. She is located in the Dallas Fort Worth Metroplex holds a Medical Degree and a Master's Degree from the University of Oklahoma. She has certifications in both Preventive Medicine and Wellness Coordination from the prestigious Cooper Institute.

Connect with Dr. Jill:

Dr. Jill’s Instagram

Dr. Jill’s Facebook

Dr. Jill’s Twitter

Dr. Jill’s Website

To become a patient visit:

Methodist Premier Wellness or call (972) 298-2099

Connect with Dr. Jill:

Dr. Jill’s Instagram

Dr. Jill’s Facebook

Dr. Jill’s Website

  continue reading

32 episodios

كل الحلقات

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida